NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wayfinder Biosciences

Wayfinder Biosciences

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.wayfinderbio.com/

Last Round

Seed

Oct 17, 2022

Total Funding Raised

$4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Wayfinder Biosciences is a biotechnology company developing a new class of orally available RNA-targeting medicines to stop disease proteins before they are made.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

RNA-targeting small moleculessmall molecule discoverydrug discovery platformAI drug discoveryundruggable targetsAI biotechmRNA targetingorally available drugshigh-throughput screeningvirtual screeningoncology drug discoverypharma partnershipsc-Myc inhibitorneurodegeneration drugsrare disease therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wayfinder Biosciences Comparables

Compare Wayfinder Biosciences with similar companies based on industry and business-model similarity.

Wayfinder Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Wayfinder Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 17, 2022
AcceleratorJan 14, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

David Sparkman-Yager

Co-Founder, CTO

Founding Team

Jason Fontana

Co-Founder & CEO

Founding Team

Wayfinder Biosciences Investors

Notable investors and investment history

Wayfinder Biosciences investors
InvestorRounds
Notation CapitalSeed
NotleySeed
IndieBioSeed, Accelerator
BoxOne VenturesSeed
Conscience VCSeed
Joyance PartnersSeed
Overlap HoldingsSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 80% MoM.

  • Jan 21, 2026

    Monthly visitors increased 33% MoM.

View all signals

Wayfinder Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wayfinder Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wayfinder Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range16
Year Founded2021
Last FundingOct 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.